Industry News

Roche announces changes to its board of directors scheduled for March 4, 2014.

Charles River Laboratories makes organizational changes to improve the company's productivity initiatives.

Moberg Pharma will acquire three OTC brands from Bayer HealthCare.

GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.

Phillips-Medisize announces the expansion to its Kontiolahti, Finland site.

BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.

The University of Missouri's Department of Biochemistry and ABC Laboratories announce industry internship program.

Harlan announces Hiroharu Okochi as president of Harlan Japan.

Johnson&Johnson will open a network of partnering offices across the UK.

AstraZeneca will receive $76 million in damages from Apotex Corp., Apotex, and Torpharm.

Shire's United States subsidiary enters supply agreement for Adderall XR.

Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.

ScinoPharm completes new API manufacturing plant in Changshu, China.

Octapharma and Pfizer form an agreement for the future marketing and commercialization of human prothrombin complex concentrate.

Researchers at Massachusetts recently reported on the development of a drug-eluting contact lens designed to provide prolonged delivery of the glaucoma medication, latanoprost.

Novasep expands its presence in India with the opening of Novasep Process Engineering Services, a part of its industrial business unit.

The flexible biomanufacturing system uses single-use technology.

PharmaCheck, a portable tool designed to detect poor-quality medicines, has been selected by Scientific American as one of the magazine?s World Changing Ideas of 2013.

LSNE appoints Shawn Cain as COO, a new position within the company.

Facility in Germany provides space for evaluating continuous pharmaceutical processing equipment.

SGS Life Science Services announced that its bioanalytical laboratory in Poitiers, France has received GMP certification, following approval from ANSM.

Aptuit appoints Jonathan Goldman as CEO.

American Association of Pharmaceutical Scientists Foundation to assist current and future scientists.

Whitehouse Laboratories announces the development of a Container Testing Center to open in 2014.

Catalent opens clinical-trial supply facility in Shanghai, China.

Baxter and Cell Therapeutics enter a licensing agreement to develop and commercialize pacritinib.

Almac releases an enhanced third-party logistics customer billing application.

Harlan Korea appoints Kwan Goo Edmond (Ed) Cho as its new president.

Sanofi discontinues development for its investigational JAK2 inhibitor, fedratinib.

Pure MHC and Catalent sign an agreement to develop RL21A using Catalent's GPEx technology.